ExpreS2ion Biotechnologies

Denmark · 29 Employees
ExpreS2ion Biotechnologies is a clinical-stage DK based biotech company specialised in the development of new vaccines and immunotherapy products. The company has a discovery platform built around a proprietary recombinant expression system, ExpreS2 TM, developed especially for fast and efficient development and production of complex proteins required for innovative new vaccines, immunotherapy and diagnostics. The system also includes functionally modified glycosylation variants. The development pipeline includes two different malaria vaccine projects in clinical Phase II (blood-stage malaria) and clinical Phase I (pregnancy-associated malaria), respectively. For the clinical Phase I/II-stage COVID-19 vaccine, ABNCoV2, the Company employs a novel plug-&-play capsid virus-like particle (cVLP) platform, that offers competitive advantages in terms of long-term efficacy, safety, stability, and costing. The cVLP and ExpreS2 TM platforms are also basis for a proprietary HER2-cVLP breast cancer vaccine, ES2B-C001, which has proven preclinical proof of concept. Furthermore, ExpreS2ion also develops novel influenza vaccines currently in preclinical development. Since founded in 2010, ExpreS2ion has produced more than 300 proteins and 40 virus-like particles (VLPs) in collaboration with a high number of leading research institutions, biotech and pharma companies, demonstrating superior efficiency and success rates. The cVLP platform resides in its joint venture partner AdaptVac that was founded in 2017. ExpreS2ion Biotechnologies ApS is a fully owned Danish subsidiary and operational unit of ExpreS2ion Biotech Holding AB, listed on Nasdaq first North, Stockholm (Ticker: EXPRS2).

概述

国家 Denmark
成立时间 2010
总部 Agern Allé 1, Horsholm, 2970, DK
电话号码 +45 22 22 10 19
网站 http://www.expres2ionbio.com
LinkedIn http://www.linkedin.com/company/expres2ion-biotechnologies
Twitter https://twitter.com/expres2ionb
Facebook
员工数 29
行业 biotechnology,
简介 ExpreS2ion Biotechnologies is a clinical-stage DK based biotech company specialised in the development of new vaccines and immunotherapy products. The company has a discovery platform built around a proprietary recombinant expression system, ExpreS2 TM, developed especially for fast and efficient development and production of complex proteins required for innovative new vaccines, immunotherapy and diagnostics. The system also includes functionally modified glycosylation variants. The development pipeline includes two different malaria vaccine projects in clinical Phase II (blood-stage malaria) and clinical Phase I (pregnancy-associated malaria), respectively. For the clinical Phase I/II-stage COVID-19 vaccine, ABNCoV2, the Company employs a novel plug-&-play capsid virus-like particle (cVLP) platform, that offers competitive advantages in terms of long-term efficacy, safety, stability, and costing. The cVLP and ExpreS2 TM platforms are also basis for a proprietary HER2-cVLP breast cancer vaccine, ES2B-C001, which has proven preclinical proof of concept. Furthermore, ExpreS2ion also develops novel influenza vaccines currently in preclinical development. Since founded in 2010, ExpreS2ion has produced more than 300 proteins and 40 virus-like particles (VLPs) in collaboration with a high number of leading research institutions, biotech and pharma companies, demonstrating superior efficiency and success rates. The cVLP platform resides in its joint venture partner AdaptVac that was founded in 2017. ExpreS2ion Biotechnologies ApS is a fully owned Danish subsidiary and operational unit of ExpreS2ion Biotech Holding AB, listed on Nasdaq first North, Stockholm (Ticker: EXPRS2).

技术

Apache

Load Balancers

Cision

Other

Google Analytics

Analytics and Tracking

Google Font API

Fonts

Google Tag Manager

Tag Management

MailChimp

Email Marketing

MailChimp SPF

Other

Mobile Friendly

Other

Nginx

Load Balancers

Outlook

Email Providers

Vimeo

Online Video Platforms

Woo Commerce

E-commerce Platforms

WordPress.org

CMS

reCAPTCHA

Captcha

常见问题

ExpreS2ion Biotechnologies 在哪里?

ExpreS2ion Biotechnologies 的总部位于 Agern Allé 1, Horsholm, 2970, DK

ExpreS2ion Biotechnologies 的电话号码是多少?

ExpreS2ion Biotechnologies 的电话号码是 +45 22 22 10 19

ExpreS2ion Biotechnologies 的官方网站是什么?

ExpreS2ion Biotechnologies 的公司官方网站是 http://www.expres2ionbio.com

ExpreS2ion Biotechnologies 是做什么的?

ExpreS2ion Biotechnologies 的业务有哪些?

drosophila s2 insect cells,upstream process development,process development for protein based vaccines,discovery platform,protein antigens

ExpreS2ion Biotechnologies 的年收入是多少?

ExpreS2ion Biotechnologies 的收入是 7000000美元

ExpreS2ion Biotechnologies 有多少员工?

ExpreS2ion Biotechnologies 有 29 名员工

ExpreS2ion Biotechnologies 属于哪个行业?

ExpreS2ion Biotechnologies 从事以下行业: biotechnology

ExpreS2ion Biotechnologies 使用什么技术?

ExpreS2ion Biotechnologies 使用的一些流行技术包括: Apache,Cision,Google Analytics,Google Font API,Google Tag Manager,MailChimp,MailChimp SPF,Mobile Friendly,Nginx,Outlook,Vimeo,Woo Commerce,WordPress.org,reCAPTCHA

如何联系 ExpreS2ion Biotechnologies?

ExpreS2ion Biotechnologies 联系信息: 电话号码:+45 22 22 10 19， 网站:http://www.expres2ionbio.com， 邮箱：scl***@***.com

ExpreS2ion Biotechnologies 的社交媒体链接是什么?

ExpreS2ion Biotechnologies 领英：http://www.linkedin.com/company/expres2ion-biotechnologies,fackbook：,twitte:https://twitter.com/expres2ionb

ExpreS2ion Biotechnologies 是一家上市公司吗?

不是

ExpreS2ion Biotechnologies 的最后一轮融资是什么时候?

ExpreS2ion Biotechnologies在2019-12-12T00:00:00.000+00:00结束了最后一轮融资,金额达2.7Mkr。

谁投资 ExpreS2ion Biotechnologies?

ExpreS2ion Biotechnologies 有 2 家投资者,包括 Horizon 2020、Modelio Equity AB。

管理层

Stine Clemmensen

Cell Culture Manager

Bahram Daneshvar

Quality Manager

Shan Feng

Senior Scientist

David Barfred

Project Lead

Laura Andersson

Senior laborant

员工

Keith Alexander

Chief Financial Officer

Magdalena Skrzypczak

Upstream Scientist

Michele Cacciapuoti

Research Scientist

Ida Nielsen

Scientist

Greta Kaselyte

Laboratory Technician, Downstream

外贸获客 查找关键决策人

10亿+海关交易数据，1.2亿企业数据，2亿+企业联系人数据，1000千万真实采购商。覆盖200+个国家及地区，95%外贸重点拓展市场，可根据行业、经营范围等多方位挖掘目标客户。
免费试用

Top-ranked on G2 Crowd

全球B2B企业库 海关贸易数据 展会采购数据

工作更少，成就更大，销售更聪明

查找更多 B2B 联系人，丰富并验证记录
Email Address

全球B2B企业库

海关贸易数据

展会采购数据

Top-ranked on G2 Crowd

OR
Sign Up with Google